INS and type 2 diabetes mellitus: Ginsenoside Rb1 ameliorated the HFD-induced increase in FBG, impaired glucose tolerance, and reduced insulin sensitivity to exert its anti-diabetes effects in a HFD-induced mouse model for T2DM (p < 0.01) [79].